Skip to Content

Interpace Biosciences Inc IDXG

Morningstar Rating
$1.45 −0.02 (1.36%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

IDXG is trading at a 50% discount.
Price
$1.46
Fair Value
$6.95
Uncertainty
Extreme
1-Star Price
$87.65
5-Star Price
$6.60
Economic Moat
Tqwhrsw
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if IDXG is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$1.47
Day Range
$1.421.45
52-Week Range
$0.623.54
Bid/Ask
$1.43 / $1.57
Market Cap
$6.35 Mil
Volume/Avg
6,513 / 6,836

Key Statistics

Price/Earnings (Normalized)
2.72
Price/Sales
0.16
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield
0.50%

Company Profile

Interpace Biosciences Inc is a fully integrated commercial company. It provides molecular diagnostics, bioinformatics and pathology services for evaluation of risk of cancer by leveraging the latest technology in personalized medicine for improved patient diagnosis and management. The company develops and commercializes genomic tests and related first line assays principally focused on early detection of patients with indeterminate biopsies and at high risk of cancer using the latest technology.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Small Value
Total Number of Employees
108

Valuation

Metric
IDXG
Price/Earnings (Normalized)
2.72
Price/Book Value
Price/Sales
0.16
Price/Cash Flow
1.66
Price/Earnings
IDXG

Financial Strength

Metric
IDXG
Quick Ratio
0.49
Current Ratio
0.59
Interest Coverage
2.12
Quick Ratio
IDXG

Profitability

Metric
IDXG
Return on Assets (Normalized)
11.59%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
IDXG
See how this stock stacks up to its competitors with Morningstar Investor

Diagnostics & Research Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
TMO
Thermo Fisher Scientific IncWydgzpkgdQgb$206.7 Bil
DHR
Danaher CorpCtdnqrtfpbQmtwfk$175.0 Bil
IQV
IQVIA Holdings IncVcfgtybTzcqgx$41.3 Bil
IDXX
IDEXX Laboratories IncJcgdpqrjkkMzjhss$39.7 Bil
A
Agilent Technologies IncDygnkzcnNnwd$38.8 Bil
MTD
Mettler-Toledo International IncYblnwnglzKttbd$25.5 Bil
ICLR
Icon PLCQkkbgtprpGpbpgcz$24.1 Bil
ILMN
Illumina IncHpxydjqnsVtznys$18.6 Bil
WAT
Waters CorpJpdfppdcDmsz$18.0 Bil
LH
Laboratory Corp of America HoldingsRrnsdjgkPjyxqj$16.8 Bil

Sponsor Center